We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0589 | 11.3051823417 | 0.521 | 0.619 | 0.49 | 148732 | 0.54590039 | CS |
4 | 0.0199 | 3.55357142857 | 0.56 | 0.7999 | 0.44 | 357371 | 0.56761941 | CS |
12 | 0.0499 | 9.41509433962 | 0.53 | 1.09 | 0.44 | 284471 | 0.64158622 | CS |
26 | -0.2281 | -28.2301980198 | 0.808 | 1.1099 | 0.44 | 243939 | 0.74750508 | CS |
52 | -0.2802 | -32.577607255 | 0.8601 | 1.87 | 0.44 | 130497 | 0.7753478 | CS |
156 | -5.0201 | -89.6446428571 | 5.6 | 5.88 | 0.44 | 64122 | 1.52924153 | CS |
260 | -14.3801 | -96.1236631016 | 14.96 | 19.56 | 0.44 | 343760 | 10.35460443 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions